XENE
Xenon Pharmaceuticals Inc.
$60.54
-0.42 (-0.69%)
At close · Jul 6
Market Cap
$5.85B
Shares
96,665,550
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$60.54
Open$60.78
Day$59.62–61.17
52W$30.00–63.95
Avg vol 30d1.6M
Short int4.4M · 4.6% float · 3.2d
Short vol34%
Last earningsMay 7, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+27% above
+
Price vs 50-day avg
+10% above
−
RSI (14)
70 · overbought
+
MACD trend
positive
+
52-week position
90% · near high
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $55 › 200d $47 — 50d above 200d
−
Institutional flow
6 of 294 funds reported for Jun 30 · net -19.7K sh shares · +2 new
−
Insider flow
Net -$133.5K over 90 days · 100% sells
−
Short interest
4.56% of float · ▲ +9.0% MoM · 3.2 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
294 holders — near 3-yr high, broad support
Fundamentals
Weak
−
Revenue growth
−83% Y/Y
−
EPS growth
−45% Y/Y
−
Free cash flow
$-279.9M
+
Balance sheet
net cash $199.2M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 3, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+27% above
Bullish
Price vs 50-day avg
+10% above
Bullish
RSI (14)
70 · overbought
Bearish
MACD trend
positive
Bullish
52-week position
90% · near high
Bullish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $55 › 200d $47 — 50d above 200d
Institutional flow
Distributing
6 of 294 funds reported for Jun 30 · net -19.7K sh shares · +2 new
Insider flow
Distributing
Net -$133.5K over 90 days · 100% sells
Short interest
Rising
4.56% of float · ▲ +9.0% MoM · 3.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
294 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $30
Now $61 · 90%
52-wk high $64
vs 200-day avg +27%
vs 50-day avg +10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XENE
this stock
Xenon Pharmaceuticals Inc.
|
$5.85B | +35.1% | -82.8% | — | 4.6% |
|
ONC
BeOne Medicines Ltd.
|
$488.96B | +1.9% | +22179.2% | 995.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.92B | +16.8% | +46.2% | 31.1 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.33B | -15.7% | +20.8% | 16.1 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XENE | +1.3% | +14.3% | +43.6% | +0.3% | +35.1% |
| SPY | +3.1% | -0.8% | +8.2% | +0.6% | +10.2% |
| vs SPY | -1.7% | +15.0% | +35.4% | -0.3% | +24.9% |